Skip to main content
Advicenne logo

Advicenne — Investor Relations & Filings

Ticker · ALDVI ISIN · FR0013296746 LEI · 969500YT5VMEYAYODW34 PA Manufacturing
Open in API
Filings indexed 259 across all filing types
Latest filing 2024-02-08 Major Shareholding Noti…
Country FR France
Listing PA ALDVI

About Advicenne

https://advicenne.com

Advicenne is a specialty pharmaceutical company dedicated to developing and commercializing treatments for rare renal diseases. The company focuses on addressing unmet medical needs in nephrology for both children and adults. Its lead product, Sibnayal®, is an approved treatment for distal Renal Tubular Acidosis (dRTA). Advicenne is committed to improving the lives of patients with rare kidney conditions by developing therapeutics, including pediatric-friendly formulations, suitable for patients of all ages.

Recent filings

Filing Released Lang Actions
Franchissement de seuils et déclaration d'intention
Major Shareholding Notification Classification · 1% confidence The document is titled "Déclaration de franchissement de seuils et déclaration d'intention" (Declaration of crossing thresholds and declaration of intent) and references French commercial code articles (L. 233-7 and L. 233-7-1) and AMF regulations. It details a change in the percentage of voting rights held by Caisse des dépôts et consignations (CDC) in ADVICENNE, crossing the 25% threshold, and includes a declaration of future intentions regarding the company. This type of mandatory disclosure regarding changes in significant share ownership or control thresholds is specifically covered by the Major Shareholding Notification category (MRQ).
2024-02-08 French
Informations privilégiées / Information sur chiffre d’affaires annuel
Earnings Release Classification · 1% confidence The document is a press release dated January 23, 2024, announcing the company's gross sales for the full year 2023. It provides key financial figures (sales growth, product performance breakdown) and management commentary. This format, focusing on preliminary or period-end financial highlights rather than the comprehensive annual filing (10-K) or a detailed quarterly report (IR), strongly aligns with an Earnings Release (ER). It is not a full transcript (CT), a formal annual report (10-K), or a mere announcement of a report publication (RPA). FY 2023
2024-01-23 French
Inside Information / Information on annual revenues
Earnings Release Classification · 1% confidence The document is a press release dated January 23, 2024, announcing the company's '2023 gross sales' figures, comparing them to 2022, and providing commentary from the CEO. This format, focusing on preliminary or summarized financial results for a period (the full year 2023), aligns perfectly with the definition of an Earnings Release (ER). It is not a comprehensive Annual Report (10-K), a full Audit Report (AR), or a detailed Management Discussion & Analysis (MDA). It is the initial announcement of the period's financial performance highlights. FY 2023
2024-01-23 English
Informations privilégiées / Autres communiqués
Report Publication Announcement Classification · 1% confidence The document is titled "Advicenne annonce son calendrier financier 2024" (Advicenne announces its 2024 financial calendar). It explicitly lists future dates for key corporate events, including the publication of 2023 sales, 2023 annual results, the Annual General Meeting (AGM), and 2024 semi-annual results. This document is an announcement detailing *when* future reports and meetings will occur, rather than being one of the reports itself (like an ER, 10-K, or IR). According to Rule 2, a document announcing the publication of reports falls under Report Publication Announcement (RPA).
2023-12-28 French
Inside Information / Other news releases
Report Publication Announcement Classification · 1% confidence The document is a press release titled "Advicenne announces its 2024 financial calendar." It explicitly lists future dates for key events like the '2023 sales release,' '2023 annual financial statement,' 'AGM,' and '2024 First Half financial statement.' Since the document's primary function is to announce the schedule for future report publications rather than containing the full content of those reports (like a 10-K or IR), it fits the definition of a Report Publication Announcement (RPA). The document length (2965 chars) is short, supporting the RPA classification over the actual report classification.
2023-12-28 English
Franchissement de seuils et déclaration d'intention
Major Shareholding Notification Classification · 1% confidence The document is a formal declaration filed in France (indicated by references to 'code de commerce' and 'AMF') regarding the crossing of ownership thresholds (10% and 15%) in the company ADVICENNE by Cemag Invest. This type of filing, which reports changes in significant share ownership levels by an entity, directly corresponds to the definition of a Major Shareholding Notification. The French equivalent of such a filing often involves reporting changes in holdings that cross statutory thresholds, which aligns perfectly with the 'MRQ' category (Major Shareholding Notification). The document explicitly details the new percentage holdings and the intention regarding future actions, confirming it is a notification of a change in major shareholding.
2023-10-10 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.